September 22, 2025

ICON plc (ICLR) Investor Outlook: Navigating Volatility with a 23.95% Potential Upside

Investors looking for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing candidate. The company, headquartered in Dublin, Ireland, is a global..

Masimo Corporation (MASI) Stock Analysis: Exploring a 33.57% Potential Upside for Investors

Masimo Corporation (MASI), a prominent player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical devices industry. Headquartered in..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Leader Faces Mixed Signals Amidst Market Volatility

Investors with a keen eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) intriguing, particularly given its longstanding reputation in the eye..

Biogen Inc. (BIIB) Stock Analysis: Unpacking a 19% Upside Potential Amidst Healthcare Innovation

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its innovative approach to neurological and neurodegenerative disease treatments. With a..

Bruker Corporation (BRKR) Stock Analysis: Evaluating a 40.87% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing the attention of investors with its promising..

Madrigal Pharmaceuticals (MDGL): Growth Potential in Biotech with a 9.53% Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising pipeline in the healthcare..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 24% Potential Upside in the Biotech Arena

Royalty Pharma plc (NASDAQ: RPRX) is carving out a distinct niche in the healthcare sector as a prominent player in the biotechnology industry. Specializing in the..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Giant with 7.36% Upside Potential

ResMed Inc. (RMD) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $40..

RadNet, Inc. (RDNT): Investor Outlook on a Promising Healthcare Innovator with 3.72% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $5.88 billion, RadNet..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 100% Revenue Growth and a Promising 13.42% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a formidable player in the biotechnology sector, focusing primarily on RNA-targeted medicines. With a market capitalization of $9.72 billion, Ionis..

Alkermes plc (ALKS) Stock Analysis: Unlocking a 49.65% Potential Upside in Biopharmaceuticals

Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its impressive potential upside of nearly 50%, positioning itself as a compelling contender in the healthcare sector...

Stevanato Group S.p.A. (STVN) Stock Analysis: Solid Buy Ratings Propel a Promising 6.87% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) has emerged as a noteworthy player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. Headquartered in Piombino..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Analysts Predict a Staggering 73% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with a remarkable potential upside that has captured the attention of investors. With a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Understanding the 33% Upside Potential in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology industry, is making waves in the healthcare sector with its innovative approach to drug development. Based..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 11.21% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, stands as a prominent player in the medical instruments and supplies industry. With a..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Leader in Clinical Research with a Noteworthy 89% ROE

Medpace Holdings, Inc. (NASDAQ: MEDP) is a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace provides..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 41.84% Potential Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, is known for its innovative solutions in the medical instruments and supplies industry. With..

The Cooper Companies, Inc. (COO) Stock Report: Analyzing a 23.91% Potential Upside for Investors

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for..

Danaher Corporation (DHR) Stock Analysis: Uncovering a 25.94% Upside Potential in Healthcare Innovation

Danaher Corporation (NYSE: DHR), a titan in the healthcare diagnostics and research sector, commands the attention of investors with its robust market capitalization of $138.41 billion...

Fresenius Medical Care AG (FMS): Investor Outlook on a Global Leader with 19.22% Upside Potential

Fresenius Medical Care AG (NYSE: FMS), a powerhouse in the healthcare sector, stands at the forefront of providing dialysis and related services worldwide. With a market..

Search

Funds

September 22, 2025

Search

Funds

September 22, 2025

FTSE 100

Funds